Homepage-OLD

Driving groundbreaking research. Improving lives.

Helping people with an MPN live a better quality of life as we work toward answers to prevention, progression and a cure for polycythemia vera (PV), essential thrombocythemia (ET), and myelofibrosis (MF) – blood cancers collectively known as myeloproliferative neoplasms.
MPNRF by the Numbers
MPN RESEARCH FUNDED
$ 0 M
RESEARCHERS SUPPORTED
0
PROJECTS FUNDED
0

What is Primary Myelofibrosis (MF)?

Primary Myelofibrosis (MF)

PMF is a chronic blood cancer in which excessive scar tissue forms in the bone marrow and impairs its ability to produce normal blood cells.

Learn more about MF

What is Essential Thrombocythemia (ET)?

Essential Thrombocythemia (ET)

Most commonly diagnosed in women over the age of 50, ET is associated with a proliferation of platelet precursors in the bone marrow and complications frequently include blood clotting and/or bleeding.

Learn more about ET

What is Polycythemia Vera (PV)

Polycythemia Vera (PV)

The disease is most common in men over the age of 60, but anyone can develop PV. PV patients typically experience an elevated red blood cell count, an elevated platelet count and an enlarged spleen, especially over time.

Learn more about PV

Recent News

  • MPN Research Foundation: A legacy of impact

    MPN NEWS | December 4, 2025

    MPN Research Foundation: A legacy of impact Sources Kralovics, R., et al. (2002). Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera. Experimental Hematology, 30(3), 229–236. Klampfl, T., et al. (2013). Somatic mutations of calreticulin in myeloproliferative neoplasms. The New England Journal of Medicine, 369(25), 2379–2390. Moliterno, A. R.,… Read More »MPN Research Foundation: A legacy of impact

    READ MORE

    Blasts 101 — what they are and where they belong  

    MPN NEWS | October 29, 2025

    Blasts 101 — what they are and where they belong Your body constantly makes new blood cells in the bone marrow, a process called hematopoiesis. Blasts are early, still-developing cells that are in a transitionary stage between stem cells and fully mature blood cells. There are two main types of blast cells that make up… Read More »Blasts 101 — what they are and where they belong  

    READ MORE

    From CALR to the cutting edge: Dr. Ann Mullally’s view of the future of MPN Research

    MPN NEWS | October 28, 2025

    Few scientists have a clearer view of where myeloproliferative neoplasm (MPN) research is headed than Dr. Ann Mullally, MD. As a physician-scientist, Division Chief of Hematology at Stanford, and member of the MPN Research Foundation’s Scientific Advisory Board (SAB), she sits at the crossroads of patient care, clinical trials, and discovery science.  From this vantage… Read More »From CALR to the cutting edge: Dr. Ann Mullally’s view of the future of MPN Research

    READ MORE
  • Ready to do more?

    Julie and her family joined team MPN and created HikeMF to join the fight against MPNs.

    Stay Connected

    With an investment today, you can accelerate research for better outcomes.

    By supporting MPN Research Foundation, you’re also supporting countless doctors and researchers around the world who are working to find a cure for these rare diseases.

     INVEST NOW

    Want to learn more about MPNs? Be the first to know about what’s going on in the PV, ET, and MF community.
    Get our monthly update,
    “Under the Microscope”